MigraineMind research summary

Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.

Neurol Ther | 2026

Observational study
AuthorsLipton RB, Goadsby PJ, Pozo-Rosich P, Urani A, Lambru G
JournalNeurol Ther
Publication year2026
PubMed ID42717153

Summary

This study looked at how well rimegepant works for treating migraines. Researchers focused on patients using different preventive medications. The study involved participants in the United States who had 3-14 headache days in a month. They used the Migraine Buddy app to track their migraine experiences. Over 28 days, participants reported details about their headaches and treatments. The study measured how many people found pain relief and improved function after using rimegepant. It also compared rimegepant's effectiveness with other acute migraine treatments. Results showed that rimegepant helped patients find meaningful pain relief, regardless of their preventive medication type. This suggests that rimegepant can be a valuable option for many migraine sufferers. The findings may help doctors choose better treatments based on patients' existing medications and needs. Clinical relevance: This research indicates that rimegepant is effective for migraine treatment, regardless of preventive therapy used.

Related migraine research topics

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.